Showing 20 of 10300 recruiting trials
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
👨⚕️ David S. Ziegler, MD, FRACP, Sydney Children's Hospitals Network📍 20 sites📅 Started Jul 2025View details ↗
Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19
👨⚕️ Ibrahim Yakoub-Agha, MD,PhD, University Hospital, Lille📍 1 site📅 Started Jul 2025View details ↗
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma
Repurposing Mirtazapine in Rett Syndrome
👨⚕️ Enrico Tongiorgi, PhD, University of Trieste, Trieste - Italy📍 4 sites📅 Started Jul 2025View details ↗
A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
👨⚕️ Premal H Thaker, M.D., Washington University School of Medicine📍 7 sites📅 Started Jul 2025View details ↗
RecruitingNCT07048418 ↗
Aesthetic and Functional Self-Assessment Following Rhinoseptoplasty in Patients With Unilateral Cleft Lip and Palate
A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
👨⚕️ Michael Saddekni, M.D., PgDip, BCMAS, Artiva Therapeutics📍 26 sites📅 Started Jul 2025View details ↗
Femoral Arterial Cannulation in Pediatrics
👨⚕️ Amro Khalili, MD, American University of Beirut Medical Center📍 1 site📅 Started Jul 2025View details ↗
RecruitingNCT07202728 ↗
A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)
👨⚕️ Xin Lu, MD & PhD, Obstetrics & Gynecology Hospital of Fudan University📍 14 sites📅 Started Jul 2025View details ↗
Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA
Enrolling by InvitationNCT07159581 ↗
Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CT
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →